Literature DB >> 18476775

Controlling the clonal spread of Pseudomonas aeruginosa infection.

Graziella H Pereira1, Anna S Levin, Helenice Bosco Oliveira, Maria Luiza Moretti.   

Abstract

To evaluate nosocomial infections due to imipenem-resistant and imipenem-susceptible Pseudomonas aeruginosa, a case-control study that included genotyping was performed. Hospitalization for more than 15 days was independently associated with infection with an imipenem-resistant organism. Sixty-seven percent of the imipenem-resistant isolates analyzed and 23% of the imipenem-susceptible isolates analyzed belonged to a single clone. Intervention led to a decrease in the number of infections due to imipenem-resistant and imipenem-susceptible P. aeruginosa.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18476775     DOI: 10.1086/588163

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  3 in total

Review 1.  A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa.

Authors:  Anne F Voor In 't Holt; Juliëtte A Severin; Emmanuel M E H Lesaffre; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

2.  Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis.

Authors:  Gowri Raman; Esther E Avendano; Jeffrey Chan; Sanjay Merchant; Laura Puzniak
Journal:  Antimicrob Resist Infect Control       Date:  2018-07-04       Impact factor: 4.887

3.  Pseudomonas infections among hospitalized adults in Latin America: a systematic review and meta-analysis.

Authors:  Alfredo Ponce de Leon; Sanjay Merchant; Gowri Raman; Esther Avendano; Jeffrey Chan; Griselda Tepichin Hernandez; Eric Sarpong
Journal:  BMC Infect Dis       Date:  2020-03-27       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.